SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors debate the stock's valuation amidst broader AI sector concerns and recent financing announcements. Community discussions revolve around the company's long-term potential as an AI infrastructure provider versus short-term market pressures, including debt and dilution. Despite positive updates and contract wins, the stock faces headwinds from AI bubble fears and overall market volatility.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as the community anticipates a decision from the European Medicines Agency (EMA) regarding its Alzheimer's treatment, blarcamesine, following a recent oral hearing. Discussions revolve around potential outcomes, ranging from full approval to conditional approval or rejection, and the implications for patients and investors. Some traders are closely watching the stock, noting the high short interest and the potential for a short squeeze if the news is positive.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSSI is trending due to a significant after-hours drop following disappointing earnings, with revenue down 40%. The community is debating the impact of this miss, with some concerned about the company's reliance on Dell and others suggesting it's an overreaction, highlighting the company's growth potential and backlog with institutions loading up shares. Discussions revolve around whether this dip is a buying opportunity or a sign of deeper issues within the company.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to concerns about lowered FY2025 sales guidance, despite a large increase in Q3 revenue, leading to questions about management's credibility and future performance; the community is actively debating the impact of the guidance cut, comparing RCAT to competitors like ONDS, and speculating on potential catalysts like government contracts and defense spending bills in 2026. The stock's volatility and the drone sector's reliance on government contracts are also contributing to the ongoing conversation.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Federal National Mortgage Association ($FNMA) is trending amid speculation around its potential IPO and discussions regarding the government's involvement, particularly after Wall Street executives had dinner with Trump. Community members are actively debating the implications of these events, including possible share dilution and the timeline for a final resolution, referencing Bill Ackman's potential influence and upcoming presentations. The stock's price volatility and potential listing on the NYSE or TXSE is driving much of the real-time conversation.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UNH is trending as investors digest mixed signals, including potential impacts from ACA subsidy discussions and upcoming 13F filings that may reveal institutional positions, particularly Berkshire Hathaway's. Community debates center around the stock's short-term direction and long-term value, with some pointing to technical indicators suggesting oversold conditions and potential for a rebound, while others highlight broader concerns about healthcare industry shifts. The stock's reaction to both Trump's comments on insurers and potential government actions are being closely watched.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as the stock experiences a significant pullback, sparking debates about its valuation and reliance on Nvidia. The community is weighing potential bounce-back opportunities against concerns of a deeper correction in the AI sector. Discussions also involve comparing CoreWeave to competitors and scrutinizing analyst ratings amid the stock's recent volatility.

Applied Materials, Inc. provides manufacturing equipment, services and software to the semiconductor, display and related industries. It operates through the following segments: Semiconductor Systems, Applied Global Services, and Display. The Semiconductor Systems segment includes semiconductor capital equipment for etch, rapid thermal processing, deposition, chemical mechanical planarization, metrology and inspection, wafer packaging, and ion implantation. The Applied Global Services segment provides solutions to optimize equipment, performance, and productivity. The Display segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, equipment upgrades, and other display technologies for TVs, monitors, laptops, personal computers, smart phones, and other consumer-oriented devices. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is trending due to a significant after-hours drop following earnings, driven by weaker-than-expected guidance and concerns about demand in China. The community is debating whether this presents a buying opportunity or signals deeper issues within the semiconductor equipment sector, particularly regarding exposure to mature nodes and potential tariff impacts. Analysts are divided, with downgrades highlighting near-term headwinds, while others maintain a bullish long-term outlook.

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics is trending amid speculation of a potential buyout by Merck after positive Phase 3 data, with community members discussing the possibility of a bidding war and high premium. The company's flu antibody, CD388, is viewed as a key asset, potentially preparing Merck for its Keytruda patent expiration. Some traders are setting high price targets while others highlight the potential for this to be a long-term hold, due to the increased market value and future opportunities.

For every 1 sol in fees 3.3k bags are removed from the ocean. The great unbagging begins.  90% fees go directly to @TheOceanCleanup

Unbagging The Ocean

Unbagging The Ocean is trending as community members promote the coin as a fun, speculative play amidst broader market volatility. The project's mission to save the ocean is also resonating with some investors, while others are more skeptical of the coin's utility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 21,000 Shares of Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 21,000 shares of the business's stock in a transaction that occurred on Monday, November 10th. The stock was...

United Therapeutics (NASDAQ:UTHR) COO Sells $10,171,575.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) COO Michael Benkowitz sold 22,500 shares of United Therapeutics stock in a transaction that occurred on Monday, November 10th. The...

United Therapeutics Corporation $UTHR Position Boosted by Aviva PLC

Aviva PLC lifted its holdings in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 1,688.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and...

Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Weil Company Inc. Has $1.50 Million Holdings in United Therapeutics Corporation $UTHR

Weil Company Inc. increased its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 13.8% in the second quarter, according to its most recent 13F filing with the SEC. The firm...

denkapparat Operations GmbH Has $747,000 Position in United Therapeutics Corporation $UTHR

denkapparat Operations GmbH lifted its holdings in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 49.9% in the 2nd quarter, according to the company in its most recent disclosure with...

Bank of Montreal Can Sells 1,373 Shares of United Therapeutics Corporation $UTHR

Bank of Montreal Can cut its position in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 7.4% during the 2nd quarter, according to the company in its most recent Form 13F...

Promising Biotech Stocks To Consider - November 8th

Danaher, Vertex Pharmaceuticals, Moderna, Recursion Pharmaceuticals, argenex, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

United Therapeutics (NASDAQ:UTHR) CEO Sells $1,793,000.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the business's stock in a transaction on Friday, November 7th. The shares were sold at an...

Promising Biotech Stocks To Add to Your Watchlist - November 7th

Danaher, Vertex Pharmaceuticals, argenex, Recursion Pharmaceuticals, Moderna, Medpace, and United Therapeutics are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

$IONQ

$RGTI

$QBTS

$QUBT

Are you buying the dip on any of these quantum stocks? 
 
If no, drop a comment.

UTHR
United Therapeutics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UTHR News

UTHRUnited Therapeutics Corp